Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.
LinkedIn:
Twitter:
Media Releases
May 13, 2022 10:15 AM ET
May 6, 2022 1:05 PM ET
Apr 29, 2022 11:00 AM ET
Apr 27, 2022 1:30 PM ET
Apr 27, 2022 11:50 AM ET
- 1 of 23
- next ›
Recent Video
May 13, 2022 10:15 AM ET |
Apr 27, 2022 11:50 AM ET |
Apr 21, 2022 2:20 PM ET |
Recent Audio
Mar 10 |